LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm

Last updated: October 30, 2024
Sponsor: Foregut Research Foundation
Overall Status: Active - Recruiting

Phase

N/A

Condition

Heartburn (Pediatric)

Esophageal Disorders

Gastroesophageal Reflux Disease (Gerd)

Treatment

LINX Reflux Management System

Fundoplication

Clinical Study ID

NCT04695171
TRX-2019-02
  • Ages > 21
  • All Genders

Study Summary

The cohort registry is both retrospective and prospective, multicenter surveillance of subjects who underwent a prior hiatal hernia repair and Magnetic Sphincter Augmentation or fundoplication construction more than 2 years prior to initial study visit.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Subject must be at least 21 years of age and at least the minimum Age of Majorityaccording to applicable state law.

  2. Underwent primary index procedure of laparoscopic repair of a hiatal hernia largerthan 3 cm with placement of a LINX® device or construction of a fundoplication forreflux control more than 2 years prior to his/her enrollment or has completed 1 or 2of the barium swallows and GERD-HRQLs within study time points with or withouthiatal hernia recurrence.

  3. Subject is willing and able to cooperate with follow-up examinations.

  4. Subject has been informed of the study procedures and treatment and has signed aninformed consent.

Exclusion

Exclusion Criteria:

  1. The surgical procedure was completed as an emergency procedure

  2. Currently being treated with another investigational drug or investigational device

  3. Suspected or confirmed esophageal or gastric cancer

  4. Subject has Barrett's esophagus >3cm

  5. Cannot understand trial requirements or is unable to comply with follow-up schedule

  6. Pregnant or plans to become pregnant during the course of the study

  7. Medical illness (i.e. congestive heart failure) that may cause the subject to benon-compliant with or able to meet the protocol requirements or is associated withlimited life expectancy (i.e. less than 3 years)

  8. Diagnosed psychiatric disorder (e.g. bipolar, schizophrenia, etc.), subjects thatexhibit depression that are on appropriate medication(s) are allowable.

Study Design

Total Participants: 450
Treatment Group(s): 2
Primary Treatment: LINX Reflux Management System
Phase:
Study Start date:
January 14, 2021
Estimated Completion Date:
January 31, 2028

Study Description

The cohort registry is both retrospective and prospective, multicenter surveillance of subjects who underwent a prior hiatal hernia repair and anti-reflux surgery with either Magnetic Sphincter Augmentation (MSA) using LINX placement or fundoplication construction more than 2 years prior to initial study visit. Subjects will be enrolled by invitation only by participating investigators. Enrollment will consist of 300 LINX MSA patients and 150 fundoplication patients with a total of 450 from 4 sites within the United States. Data will be collected for up to 6 years.The primary objective of this study is to determine the long-term incidence of hiatal hernia recurrence in patients who undergo hiatal hernia repair of a large (>3 cm) hernia with LINX® device placement, and to compare this with hiatal hernia recurrence rates in patients who underwent hiatal hernia repair with fundoplication.

Connect with a study center

  • Keck Medical Center of USC

    Los Angeles, California 90033
    United States

    Active - Recruiting

  • Institute of Esophageal and Reflux Surgery

    Englewood, Colorado 80113
    United States

    Site Not Available

  • Institute of Esophageal and Reflux Surgery

    Lone Tree, Colorado 80124
    United States

    Active - Recruiting

  • South Florida Reflux Center

    Coral Springs, Florida 33065
    United States

    Active - Recruiting

  • East Carolina University

    Greenville, North Carolina 27858
    United States

    Active - Recruiting

  • Esophageal Institute

    Pittsburgh, Pennsylvania 15224
    United States

    Site Not Available

  • Digestive Health

    Austin, Texas 78712
    United States

    Active - Recruiting

  • University of Texas

    Austin, Texas 78712
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.